Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ZyVersa

ZyVersa
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE
$1.28M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of pharmaceuticals intended to develop first-in-class drugs. The company's drugs leverage proprietary technologies and its product pipeline includes Phase 2a ready VAR 200, hydroxypropyl beta-cyclodextrin (HPβCD) for treatment of focal segmental glomerulosclerosis (FSGS), enabling physicians to get access to innovative drug formulations for therapies and treatments.

Website
Formerly Known As
Variant Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 2200 North Commerce Parkway
  • Suite 208
  • Weston, FL 33326
  • United States

+1 (954) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ZyVersa’s full profile, request a free trial.

ZyVersa Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 01-Nov-2019 $1.28M 00.000 Completed Clinical Trials - General
3. Corporate 03-Dec-2018 0000 00.000 Completed Clinical Trials - General
2. Angel (individual) 05-Feb-2018 $1.93M $4.91M Completed Startup
1. Angel (individual) 03-Feb-2015 $2.98M $2.98M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

ZyVersa Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ACADIA Pharmaceuticals Formerly VC-backed San Diego, CA 000 00000 000000&0
000000 000000 Formerly VC-backed Laval, Canada 00 000.00 000000000 000.00
000000000 00000000 Venture Capital-Backed Cambridge, MA 00 000.00 0000000000 0 000.00
0000000 0000000000 Formerly VC-backed Lexington, MA 00 00000 000000000 00000
000000000 Formerly VC-backed South San Francisco, CA 00000 000.00 00000000000
To view this company’s complete list of competitors, request access »

ZyVersa Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Incon (surveillance systems) Corporation Minority 000 0000 000000 0

ZyVersa Executive Team (6)

Name Title Board
Seat
Contact
Info
Stephen Glover Co-Founder, President & Chief Executive Officer
Karen Cashmere Chief Commercial Officer
Peter Wolfe Senior Vice President of Finance and Administration
Pablo Guzman MD Chief Medical Officer
Nicholas LaBella Jr. Chief Scientific Officer & Senior VP Research and Development
You’re viewing 5 of 6 executives. Get the full list »

ZyVersa Board Members (6)

Name Representing Role Since Contact
Info
Aaron Greenblatt Self Board Member 000 0000
Andrew Kim ZyVersa Board Member 000 0000
Anthony Giovinazzo ZyVersa Board Member 000 0000
Eric Richman Self Board Member 000 0000
Jules Musing ZyVersa Chairman 000 0000
You’re viewing 5 of 6 board members. Get the full list »